O7-3 Phase II study of brigatinib in patients with TKI-naive ROS1-rearranged non-small cell lung cancer (NSCLC): Barossa study
- Resource Type
- Abstract
- Authors
- Takahashi, Toshiaki; Niho, Seiji; Toyozawa, Ryo; Goto, Yasushi; Ohashi, Kadoaki; Daga, Haruko; Tanaka, Hiroshi; Hattori, Yoshihiro; Morise, Masahiro; Sakakibara-Konishi, Jun; Kodani, Masahiro; Ikeda, Takaya; Matsumoto, Shingo; Yoh, Kiyotaka; Nomura, Shogo; Goto, Koichi
- Source
- In Annals of Oncology November 2023 34 Supplement 3:S1387-S1387
- Subject
- Language
- ISSN
- 0923-7534